Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G56W1 vs Teribone in postmenopausal osteoporosis
CTR20181346Phase 2Completed
- Sponsor
- Chengdu Jinkai Biotechnology
- Start
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of teriparatide in osteoporosis, sponsored by Chengdu Jinkai Biotechnology. Started Aug 2018; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on CTR20181346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181346.